Last reviewed · How we verify

NCT07000786: EUmetriosis

EUmetriosis: Insights Into the Pathogenesis of Endometriosis

Recruiting now NA Last updated 3 June 2025
What this trial tests

NA trial testing Endometrial biopsy or menstrual cup and blood sample in Endometriosis in 60 participants. Currently enrolling.

Timeline
12 May 2025
Primary endpoint
31 December 2029
31 December 2029

Quick facts

Lead sponsorUniversité Catholique de Louvain
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment60
Start date12 May 2025
Primary completion31 December 2029
Estimated completion31 December 2029
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Université Catholique de Louvain — full company profile →

Who can join

Adults 18 to 56, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates epigenetic changes in menstrual effluent and plasma from women with endometriosis to identify potential non-invasive diagnostic biomarkers for the disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Université Catholique de Louvain trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07000786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing